Literature DB >> 9190912

The regulation of p27Kip1 expression following the polyclonal activation of murine G0 T cells.

T K Kwon1, M A Buchholz, P Ponsalle, F J Chrest, A A Nordin.   

Abstract

Polyclonal activation of murine G0 T cells with immobilized anti-CD3 induces entry into the cell cycle as well as the subsequent cytokine-dependent proliferative response. G0 T cells express high levels of p27Kip1 protein and specific mRNA, which decline rapidly following activation. The decline in the expression of p27Kip1 and sequestering of the inhibitory protein by cdk4 and cdk6 correlated with the increase in cdk2 kinase activity during the G1 phase. Anti-CD3 activation of G0 T cells in the presence of cyclosporin A or rapamycin inhibited the down-regulation of p27Kip1, the cellular levels of the inhibitor remained high, and the cells remained in the G1 phase. PBu2 activation of G0 T cells also did not result in the down-regulation of p27Kip1 and the cells remained in G1. In each instance IL-2 restored the down-regulation of p27Kip1, resulting in a significant reduction in the level of the inhibitor, and stimulated the cells to progress through the cell cycle. Jurkat cells transfected with the p27GL-988 plasmid containing +1 to -988 nt of the p27Kip1 promoter region and subsequently exposed to rIL-2 resulted in a significant reduction in the activity of the p27Kip1 promoter. These findings suggest that in addition to providing the signals required for activated T cells to traverse G1/S, IL-2 also influences the promoter function of p27Kip1, which effectively induces transcriptional down-regulation of the gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9190912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation.

Authors:  Nikolaos Patsoukis; Julia Brown; Victoria Petkova; Fang Liu; Lequn Li; Vassiliki A Boussiotis
Journal:  Sci Signal       Date:  2012-06-26       Impact factor: 8.192

Review 2.  Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.

Authors:  P Höllsberg
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

3.  An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation.

Authors:  G I Kovalev; D S Franklin; V M Coffield; Y Xiong; L Su
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

4.  P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawal.

Authors:  James W Huleatt; James Cresswell; Kim Bottomly; I Nicholas Crispe
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

5.  Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.

Authors:  M H Kaplan; C Daniel; U Schindler; M J Grusby
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

6.  Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation.

Authors:  Theodore H Welling; Guanyi Lu; Keri Csencsits; Sherri C Wood; Lamis Jarvinen; D Keith Bishop
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

7.  Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cells.

Authors:  Christian R Geest; Fried J Zwartkruis; Edo Vellenga; Paul J Coffer; Miranda Buitenhuis
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

8.  Genetic disruption of p38alpha Tyr323 phosphorylation prevents T-cell receptor-mediated p38alpha activation and impairs interferon-gamma production.

Authors:  Ludmila Jirmanova; Dandapantula N Sarma; Dragana Jankovic; Paul R Mittelstadt; Jonathan D Ashwell
Journal:  Blood       Date:  2008-11-14       Impact factor: 22.113

9.  T-cell intrinsic and extrinsic mechanisms of p27Kip1 in the regulation of CD8 T-cell memory.

Authors:  Anna Jatzek; Melba Marie Tejera; Erin H Plisch; Matthew L Fero; M Suresh
Journal:  Immunol Cell Biol       Date:  2012-12-04       Impact factor: 5.126

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.